Randomized controlled phase II study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer.

被引：0
|
作者：
Nakamura, Seiichi
Tatebe, Shigeru
Shimizu, Tetsu
Yamane, Nariyuki
Nishidoi, Hideaki
Kurisu, Yasuro
Kanayama, Hirotomo
Ogawa, Haruaki
Tsujitani, Shunichi
Ikeguchi, Masahide
机构：
[1] Tottori Prefectural Cent Hosp, Tottori, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Yonago Med Ctr, Yonago, Tottori, Japan
[4] Tottori Red Cross Hosp, Tottori, Japan
[5] Hamada Med Ctr, Hamada, Japan
[6] Matsue City Hosp, Matsue, Shimane, Japan
[7] Yasugi Municipal Hosp, Yasugi, Japan
[8] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial
    Shigeru Tatebe
    Shunichi Tsujitani
    Seiichi Nakamura
    Tetsu Shimizu
    Nariyuki Yamane
    Hideaki Nishidoi
    Yasuro Kurisu
    Hirotomo Kanayama
    Haruaki Ogawa
    Masahide Ikeguchi
    Gastric Cancer, 2014, 17 : 508 - 513
  • [2] Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial
    Tatebe, Shigeru
    Tsujitani, Shunichi
    Nakamura, Seiichi
    Shimizu, Tetsu
    Yamane, Nariyuki
    Nishidoi, Hideaki
    Kurisu, Yasuro
    Kanayama, Hirotomo
    Ogawa, Haruaki
    Ikeguchi, Masahide
    GASTRIC CANCER, 2014, 17 (03) : 508 - 513
  • [3] Feasibility Study of Alternate-day S-1 as Adjuvant Chemotherapy for Head and Neck Cancer
    Moro, Yorihisa
    Kogashiwa, Yasunao
    Sato, Dai
    Matsumoto, Yoshifumi
    Nakamura, Takehiro
    Yamauchi, Koichi
    Sakurai, Hiroyuki
    Kohno, Naoyuki
    ANTICANCER RESEARCH, 2015, 35 (02) : 977 - 981
  • [4] Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)
    Tanaka, Hiroaki
    Kanda, Mitsuro
    Morita, Satoshi
    Taguri, Masataka
    Nishikawa, Kazuhiro
    Shimada, Mitsuo
    Muguruma, Kazuya
    Koeda, Keisuke
    Takahashi, Masazumi
    Nakamori, Mikihito
    Konno, Hiroyuki
    Tsuji, Akihito
    Hosoya, Yoshinori
    Shirasaka, Tetsuhiko
    Yamamitsu, Susumu
    Sowa, Michio
    Kitajima, Masaki
    Okajima, Masazumi
    Kobayashi, Michiya
    Sakamoto, Junichi
    Saji, Shigetoyo
    Hirakawa, Kosei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 1052 - 1059
  • [5] Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)
    Hiroaki Tanaka
    Mitsuro Kanda
    Satoshi Morita
    Masataka Taguri
    Kazuhiro Nishikawa
    Mitsuo Shimada
    Kazuya Muguruma
    Keisuke Koeda
    Masazumi Takahashi
    Mikihito Nakamori
    Hiroyuki Konno
    Akihito Tsuji
    Yoshinori Hosoya
    Tetsuhiko Shirasaka
    Susumu Yamamitsu
    Michio Sowa
    Masaki Kitajima
    Masazumi Okajima
    Michiya Kobayashi
    Junichi Sakamoto
    Shigetoyo Saji
    Kosei Hirakawa
    International Journal of Clinical Oncology, 2017, 22 : 1052 - 1059
  • [6] A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer
    Yoshino, S.
    Nishimura, T.
    Sakata, K.
    Yoshida, S.
    Furuya, T.
    Yamamoto, T.
    Kawaoka, T.
    Shimizu, R.
    Sato, T.
    Matoba, K.
    Morioka, H.
    Iida, M.
    Suzuki, N.
    Takeda, S.
    Ueno, T.
    Hazama, S.
    Nagano, H.
    ANNALS OF ONCOLOGY, 2016, 27 : 26 - 26
  • [7] Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer
    Ishikawa, Takuya
    Kawashima, Hiroki
    Ohno, Eizaburo
    Matsubara, Hiroshi
    Sasaki, Yoji
    Achiwa, Koichi
    Kanamori, Akira
    Sumi, Hajime
    Hirai, Takanori
    Nonogaki, Koji
    Tsuzuki, Tomoyuki
    Kuroiwa, Masanori
    Hattori, Masashi
    Maruta, Shinya
    Hiramatsu, Takeshi
    Ando, Masahiko
    Hashimoto, Senju
    Hirooka, Yoshiki
    ONCOLOGY, 2019, 96 (01) : 1 - 7
  • [8] Prospective Randomized Controlled Phase II Trial of Alternate-day Vs Consecutive-day Treatment With S-1 as Postoperative Adjuvant Therapy for Gastric Cancer: San-in Clinical Oncology Group Study No. 9
    Tsujitani, S.
    Tatebe, S.
    Ikeguchi, M.
    Maehara, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S448 - S448
  • [9] Phase I study of alternate-day administration of S-1, oral leucovorin, and bevacizumab for refractory metastatic colorectal cancer.
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Komori, Azusa
    Mitani, Seiichiro
    Hasegawa, Hiroko
    Narita, Yukiya
    Kadowaki, Shigenori
    Ura, Takashi
    Ando, Masashi
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy in advanced gastric cancer.
    Shim, H.
    Bae, W. K.
    Hwang, J.
    Yoon, J.
    Yang, D. H.
    Nam, T.
    Ryu, S.
    Park, Y.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345